Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #28,801 to #28,850.
- Assault by or harmful exposure to protozoal vaccines (Q84009)
- Assault by or harmful exposure to mumps vaccines (Q84008)
- Assault by or harmful exposure to rotavirus vaccines (Q84007)
- Assault by or harmful exposure to yellow fever vaccines (Q84006)
- Assault by or harmful exposure to rickettsial vaccines (Q84005)
- Assault by or harmful exposure to pertussis vaccine, including combinations with a pertussis component (Q84004)
- Assault by or harmful exposure to hepatitis A vaccines (Q84003)
- Assault by or harmful exposure to polio vaccines (Q84002)
- Assault by or harmful exposure to other or unspecified bacterial vaccines (Q84001)
- Assault by or harmful exposure to mixed bacterial vaccines without a pertussis component (Q84000)
- Assault by or harmful exposure to measles vaccines (Q83999)
- Assault by or harmful exposure to diphtheria vaccine (Q83998)
- Assault by or harmful exposure to other viral vaccines (Q83997)
- Assault by or harmful exposure to human papillomavirus vaccines (Q83996)
- Assault by or harmful exposure to smallpox vaccines (Q83995)
- Assault by or harmful exposure to influenza vaccines (Q83994)
- Assault by or harmful exposure to rubella vaccines (Q83993)
- Assault by or harmful exposure to hepatitis B vaccines (Q83992)
- Assault by or harmful exposure to Haemophilus influenzae type B vaccines (Q83991)
- Assault by exposure to or harmful effects of agents primarily affecting the gastrointestinal system (Q83990)
- Assault by or harmful exposure to BCG vaccine (Q83989)
- Assault by or harmful exposure to tetanus vaccine (Q83988)
- Assault by exposure to or harmful effects of topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs (Q83987)
- Assault by or harmful exposure to complementary or traditional medicines, not elsewhere classified (Q83986)
- Assault by or harmful exposure to complementary or traditional medicines, unspecified (Q83985)
- Assault by or harmful exposure to plague vaccine (Q83984)
- Assault by or harmful exposure to cholera vaccine (Q83983)
- Assault by exposure to or harmful effects of alcohol deterrents, not elsewhere classified (Q83982)
- Assault by exposure to or harmful effects of agents used for other scanning techniques (Q83981)
- Assault by exposure to or harmful effects of other diagnostic agents (Q83980)
- Assault by or harmful exposure to typhoid or paratyphoid vaccine (Q83979)
- Assault by or harmful exposure to harmful effects of vitamins or pharmaceutical excipients, not elsewhere classified (Q83978)
- Assault by or harmful exposure to vaccines, immunoglobulins or other biological substances (Q83977)
- Assault by exposure to or harmful effects of lipotropic drugs (Q83976)
- Assault by or harmful exposure to herbal preparations or formulas (Q83975)
- Assault by exposure to or harmful effects of X-ray contrast media (Q83974)
- Assault by or harmful exposure to dietary supplements, vitamins or minerals (Q83973)
- Assault by exposure to or harmful effects of appetite depressants (Q83972)
- Assault by exposure to or harmful effects of MRI contrast agents (Q83971)
- Assault by exposure to or harmful effects of agents primarily affecting blood constituents (Q83970)
- Assault by exposure to or harmful effects of agents primarily affecting water-balance or mineral or uric acid metabolism (Q83969)
- Assault by exposure to or harmful effects of agents primarily affecting the cardiovascular system (Q83968)
- Assault by exposure to or harmful effects of disulfiram (Q83967)
- Assault by exposure to or harmful effects of agents primarily acting on smooth or skeletal muscles or the respiratory system (Q83966)
- Assault by exposure to or harmful effects of systemic antibiotics (Q83965)
- Perforated stomach wound (Q83964)
- Multiple fractures of pelvis (Q83963)
- Traumatic rupture of stomach (Q83962)
- Orthopoxvirus monkeypox Clade Ib (Q83961)
- Multiple fractures of lumbar spine (Q83960)
